CS209846B2 - Method of making the benzamide derivatives containing th pyrrolidine or piperidine core - Google Patents
Method of making the benzamide derivatives containing th pyrrolidine or piperidine core Download PDFInfo
- Publication number
- CS209846B2 CS209846B2 CS752168A CS216875A CS209846B2 CS 209846 B2 CS209846 B2 CS 209846B2 CS 752168 A CS752168 A CS 752168A CS 216875 A CS216875 A CS 216875A CS 209846 B2 CS209846 B2 CS 209846B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- compound
- compounds
- formula
- benzamide
- bis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS802611A CS209847B2 (cs) | 1974-04-01 | 1980-04-15 | Způsob výroby derivátů bsnzamidu obsahujících pyrrolidinové nebo piperidinové jádro |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US457099A US3900481A (en) | 1974-04-01 | 1974-04-01 | Derivatives of pyrrolidine and piperidine |
Publications (1)
Publication Number | Publication Date |
---|---|
CS209846B2 true CS209846B2 (en) | 1981-12-31 |
Family
ID=23815433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS752168A CS209846B2 (en) | 1974-04-01 | 1975-03-28 | Method of making the benzamide derivatives containing th pyrrolidine or piperidine core |
Country Status (22)
Country | Link |
---|---|
US (1) | US3900481A (xx) |
JP (2) | JPS5827268B2 (xx) |
AR (1) | AR210990A1 (xx) |
BE (1) | BE827354A (xx) |
CA (1) | CA1054602A (xx) |
CH (1) | CH618425A5 (xx) |
CS (1) | CS209846B2 (xx) |
DE (1) | DE2513916C2 (xx) |
DK (1) | DK158980C (xx) |
ES (1) | ES435870A1 (xx) |
FR (1) | FR2265366B1 (xx) |
GB (1) | GB1508015A (xx) |
HU (1) | HU169762B (xx) |
IE (1) | IE41224B1 (xx) |
IL (1) | IL46967A (xx) |
NL (1) | NL186633C (xx) |
NO (1) | NO144262C (xx) |
OA (1) | OA04912A (xx) |
PL (1) | PL95576B1 (xx) |
SE (1) | SE391336B (xx) |
SU (1) | SU668599A3 (xx) |
ZA (1) | ZA751040B (xx) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4197243A (en) * | 1975-04-02 | 1980-04-08 | Yamanouchi Pharmaceutical Co., Ltd. | N-1-Benzyl-3-pyrrolidinyl-4-dimethylamino benzamide derivatives |
GB1520584A (en) * | 1975-04-02 | 1978-08-09 | Yamanouchi Pharma Co Ltd | 2 - alkoxy - 5 substituted benzamide derivatives and their use in pharmaceutical compositions |
FI763021A (xx) * | 1975-11-03 | 1977-05-04 | Thomae Gmbh Dr K | |
US4071524A (en) * | 1976-11-08 | 1978-01-31 | Riker Laboratories, Inc. | Derivatives of urea |
US4097481A (en) * | 1976-11-08 | 1978-06-27 | Riker Laboratories, Inc. | Tertiary amide derivatives of pyrrolidine and piperidine |
GB2097000B (en) * | 1979-03-19 | 1983-11-30 | Riker Laboratories Inc | Process for the preparation of 1,4-bis(2,2,2-trifluoroethoxy) benzene |
US4684733A (en) * | 1979-03-19 | 1987-08-04 | Riker Laboratories, Inc. | Process for the preparation of intermediates of derivatives of pyrrolidine and piperidine |
US4617396A (en) * | 1979-03-19 | 1986-10-14 | Riker Laboratories, Inc. | Process for the preparation of derivatives of piperidine |
ZA801565B (en) * | 1979-03-19 | 1981-05-27 | Riker Laboratories Inc | Process for the preparation of 2,5-bis(2,2,2-trifluoroethoxy)-n-(2-piperidylmethyl)benzamide |
US4642384A (en) * | 1979-03-19 | 1987-02-10 | Riker Laboratories, Inc. | Process for the preparation of derivatives of pyrrolidine and piperidine |
US4390716A (en) * | 1981-06-08 | 1983-06-28 | Riker Laboratories, Inc. | Phenolic derivative |
US4339587A (en) * | 1981-06-08 | 1982-07-13 | Riker Laboratories, Inc. | 5-Benzyloxy or 5-hydroxy-2-(2,2,2-trifluoroethoxy)-N-(2-pyridylmethyl)benzamide |
US4452983A (en) * | 1981-06-08 | 1984-06-05 | Riker Laboratories, Inc. | Phenolic derivative |
JPS5970666A (ja) * | 1982-10-15 | 1984-04-21 | Kyowa Hakko Kogyo Co Ltd | 1,4−ジヒドロピリジン誘導体 |
US4555573A (en) * | 1983-11-15 | 1985-11-26 | Riker Laboratories, Inc. | Certain 6-benzamidomethyl-2(1H)-pyridone derivatives |
US4656285A (en) * | 1983-11-15 | 1987-04-07 | Riker Laboratories, Inc. | Compound 2-acetamidomethyl-6-methoxy-pyridine |
US4496734A (en) * | 1983-11-15 | 1985-01-29 | Riker Laboratories, Inc. | Metabolite |
US4497954A (en) * | 1983-11-15 | 1985-02-05 | Riker Laboratories, Inc. | Cyclopentanone derivatives |
US4599434A (en) * | 1983-11-15 | 1986-07-08 | Riker Laboratories, Inc. | Cyclopentanone derivatives |
EP0242847B1 (en) * | 1986-04-25 | 1993-06-02 | Abbott Laboratories | Tracers for use in flecainide fluorescence polarization immunoassay |
NZ219913A (en) * | 1986-04-25 | 1990-08-28 | Riker Laboratories Inc | Various flecainide derivatives and antibodies raised thereto |
US5336622A (en) * | 1986-04-25 | 1994-08-09 | Abbott Laboratories | Tracers for use in flecainide fluorescence polarization immunoassay |
US4952574A (en) * | 1988-09-26 | 1990-08-28 | Riker Laboratories, Inc. | Antiarrhythmic substituted N-(2-piperidylmethyl)benzamides |
US4938966A (en) * | 1988-11-30 | 1990-07-03 | Riker Laboratories, Inc. | Controlled release flecainide acetate formulation |
US5254569A (en) * | 1991-01-14 | 1993-10-19 | The Du Pont Merck Pharmaceutical Company | (Amidomethyl)nitrogen heterocyclic analgesics |
IL121288A (en) * | 1997-07-11 | 2000-10-31 | Finetech Ltd | Process and a novel intermediate for the preparation of flecainide |
ITMI20011772A1 (it) * | 2001-08-10 | 2003-02-10 | A M S A Anonima Materie Sint E | Processo per la preparazione della 2,5-bis-(2,2,2-trifluoroetossi)-n-(2-piperidilmetil)-benzamide(flecainide) |
EP1500651A1 (en) * | 2003-07-25 | 2005-01-26 | Bayer CropScience S.A. | N-[2-(2-Pyridinyl)ethyl]benzamide compounds and their use as fungicides |
US7196197B2 (en) * | 2003-09-17 | 2007-03-27 | Apotex Pharmachem Inc. | Process for the preparation of Flecainide, its pharmaceutically acceptable salts and important intermediates thereof |
EP1918280A1 (en) * | 2006-11-06 | 2008-05-07 | "Joint Stock Company Grindeks" | Process for the preparation of 2,5-bis-(2,2,2-trifluoroethoxy)-N-(2-piperidylmethyl)-benzamide and salts thereof |
WO2008063603A2 (en) | 2006-11-20 | 2008-05-29 | President And Fellows Of Harvard College | Methods, compositions, and kits for treating pain and pruritis |
JP4946482B2 (ja) | 2007-02-08 | 2012-06-06 | 船井電機株式会社 | 緩衝用梱包材及びtv受像機の緩衝用梱包材 |
CA2767646C (en) | 2009-07-10 | 2019-01-29 | President And Fellows Of Harvard College | Permanently charged sodium and calcium channel blockers as anti-inflammatory agents |
KR20180069782A (ko) | 2015-08-03 | 2018-06-25 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 하전 이온 채널 블록커 및 이용 방법 |
US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
EP3937945A4 (en) | 2019-03-11 | 2023-01-04 | Nocion Therapeutics, Inc. | CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE |
JP2022527731A (ja) | 2019-03-11 | 2022-06-06 | ノシオン セラピューティクス,インコーポレイテッド | エステル置換イオンチャンネル遮断薬および使用方法 |
JP2022527438A (ja) | 2019-03-11 | 2022-06-02 | ノシオン セラピューティクス,インコーポレイテッド | 荷電したイオンチャンネル遮断薬および使用方法 |
US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
JP7513713B2 (ja) | 2019-11-06 | 2024-07-09 | ノシオン セラピューティクス,インコーポレイテッド | 荷電したイオンチャンネル遮断薬および使用方法 |
BR112022008575A2 (pt) | 2019-11-06 | 2022-08-09 | Nocion Therapeutics Inc | Bloqueadores de canal iônico carregado e métodos para uso |
CN115279731A (zh) | 2020-03-11 | 2022-11-01 | 诺西恩医疗公司 | 带电的离子通道阻滞剂及其使用方法 |
WO2024132080A1 (en) | 2022-12-22 | 2024-06-27 | Colonis Pharma Ltd | Liquid pharmaceutical composition containing flecainide and process for the preparaton thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR6209M (xx) * | 1967-04-03 | 1968-07-29 | ||
US3655728A (en) * | 1970-07-22 | 1972-04-11 | Riker Laboratories Inc | N-(2 - dialkylaminoalkylene)-esters of fluoroalkoxy-substituted aryl carboxylic acid and salts thereof |
US3719687A (en) * | 1970-07-22 | 1973-03-06 | Riker Laboratories Inc | N-(2-dialkylaminoalkylene)amides of 1,1-dihydroperfluoroalkoxy-substituted aryl acids and salts thereof |
-
1974
- 1974-04-01 US US457099A patent/US3900481A/en not_active Expired - Lifetime
-
1975
- 1975-02-19 ZA ZA00751040A patent/ZA751040B/xx unknown
- 1975-03-21 DK DK119675A patent/DK158980C/da active
- 1975-03-21 NL NLAANVRAGE7503389,A patent/NL186633C/xx not_active IP Right Cessation
- 1975-03-21 SE SE7503262A patent/SE391336B/xx active Protection Beyond IP Right Term
- 1975-03-21 NO NO750976A patent/NO144262C/no unknown
- 1975-03-21 ES ES435870A patent/ES435870A1/es not_active Expired
- 1975-03-27 CH CH403075A patent/CH618425A5/de not_active IP Right Cessation
- 1975-03-27 GB GB13027/75A patent/GB1508015A/en not_active Expired
- 1975-03-27 DE DE2513916A patent/DE2513916C2/de not_active Expired
- 1975-03-27 CA CA223241A patent/CA1054602A/en not_active Expired
- 1975-03-27 IE IE700/75A patent/IE41224B1/xx unknown
- 1975-03-27 OA OA55453A patent/OA04912A/xx unknown
- 1975-03-28 HU HURI561A patent/HU169762B/hu unknown
- 1975-03-28 CS CS752168A patent/CS209846B2/cs unknown
- 1975-03-28 FR FR7509953A patent/FR2265366B1/fr not_active Expired
- 1975-03-28 BE BE154920A patent/BE827354A/xx active Protection Beyond IP Right Term
- 1975-03-31 SU SU752117802A patent/SU668599A3/ru active
- 1975-03-31 AR AR258179A patent/AR210990A1/es active
- 1975-03-31 JP JP50039035A patent/JPS5827268B2/ja not_active Expired
- 1975-03-31 IL IL46967A patent/IL46967A/xx unknown
- 1975-04-01 PL PL1975179258A patent/PL95576B1/pl unknown
-
1982
- 1982-08-27 JP JP57149020A patent/JPS5858347B2/ja not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR2265366B1 (xx) | 1980-01-11 |
JPS5865268A (ja) | 1983-04-18 |
DK158980B (da) | 1990-08-13 |
NL186633B (nl) | 1990-08-16 |
DE2513916A1 (de) | 1975-10-09 |
NO750976L (xx) | 1975-10-02 |
DK158980C (da) | 1991-01-07 |
JPS50137975A (xx) | 1975-11-01 |
IE41224L (en) | 1975-10-01 |
OA04912A (fr) | 1980-10-31 |
ZA751040B (en) | 1976-01-28 |
SE391336B (sv) | 1977-02-14 |
DE2513916C2 (de) | 1982-12-23 |
ES435870A1 (es) | 1976-12-16 |
CH618425A5 (xx) | 1980-07-31 |
NL7503389A (nl) | 1975-10-03 |
NL186633C (nl) | 1991-01-16 |
AR210990A1 (es) | 1977-10-14 |
IL46967A (en) | 1978-09-29 |
DK119675A (xx) | 1975-10-02 |
BE827354A (fr) | 1975-09-29 |
JPS5827268B2 (ja) | 1983-06-08 |
NO144262B (no) | 1981-04-21 |
IL46967A0 (en) | 1975-05-22 |
AU7957875A (en) | 1976-09-30 |
HU169762B (xx) | 1977-02-28 |
NO144262C (no) | 1981-07-29 |
SE7503262L (xx) | 1975-10-02 |
FR2265366A1 (xx) | 1975-10-24 |
JPS5858347B2 (ja) | 1983-12-24 |
PL95576B1 (pl) | 1977-10-31 |
IE41224B1 (en) | 1979-11-21 |
GB1508015A (en) | 1978-04-19 |
US3900481A (en) | 1975-08-19 |
CA1054602A (en) | 1979-05-15 |
SU668599A3 (ru) | 1979-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS209846B2 (en) | Method of making the benzamide derivatives containing th pyrrolidine or piperidine core | |
SU1507211A3 (ru) | Способ получени производных пиридина | |
US20030105135A1 (en) | Phenoxypropanolamines, preparation and therapeutic use thereof | |
DK143501B (da) | Analogifremgangsmaade til fremstilling af betareceptorblokerende derivater af 2-hydroxy-3-aminopropan eller terapeutisk anvendelige salte deraf | |
IE922523A1 (en) | New 5-isoquinolinesulfonamides process for preparing them and pharmaceutical compositions containing them | |
US4097481A (en) | Tertiary amide derivatives of pyrrolidine and piperidine | |
DK159114B (da) | Benzyldihydrofuropyridinderivater og praeparater indeholdende disse forbindelser | |
DE60311578T2 (de) | Inhibitoren der gpib-vwf wechselwirkung | |
US3103516A (en) | J-tertiaryaminq-lower alkyl-jb-meta- | |
JPS6123790B2 (xx) | ||
US4005209A (en) | Antiarrhythmic method utilizing fluoroalkoxy-N-piperidyl and pyridyl benzamides | |
HU207295B (en) | Process for producing pyridine-2,4- and 2,5-dicarboxylic acid derivatives and pharmaceutical compositions containing them | |
US4442102A (en) | 1,5-Diphenylpyrazolin-3-one compounds, process and intermediates for preparation thereof and pharmaceutical compositions containing same | |
US4013670A (en) | Derivatives of pyrrolidine and piperidine | |
EP0234098B1 (en) | N-[piperidylaminocarbonyl]quinolinecarboxamide derivatives having psychotropic activity | |
US2566360A (en) | Aminoalkyl ethers of pyridyl alkylene aryl compounds | |
JPH05502235A (ja) | イミダゾール類 | |
CS214841B2 (en) | Method of making the tetrahydrochinolines | |
HU193046B (en) | Process for preparing aplha-aryl-alpha-pyridyl-alkyl-carboxylic acid derivatives and pharmaceutical compositions | |
EP0006628B1 (en) | Substituted dihydropyridine ureas, process for preparing the same and pharmaceutical compositions containing them | |
US4110457A (en) | Bis-arylalkylamino-aralkanes | |
JPS62212386A (ja) | 2−ピリジルメチルベンズイミダゾ−ル誘導体 | |
JPS62108863A (ja) | 2−ピリジル酢酸誘導体、その製法およびそれを含む医薬 | |
CS209847B2 (cs) | Způsob výroby derivátů bsnzamidu obsahujících pyrrolidinové nebo piperidinové jádro | |
DE19511916A9 (de) | Neue N-Benzylindol- und Benzopyrazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung |